Sg3 Management, LLC Amgen Inc Call Options Transaction History

Sg3 Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $438,540 - $485,140	-2,000 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $7.96 Million - $9.1 Million	-40,000 Reduced 95.24%	2,000 $450,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $6.37 Million - $7.46 Million	30,000 Added 250.0%	42,000 $8.93 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $16.9 Million - $18.8 Million	-72,500 Reduced 85.8%	12,000 $2.93 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $18.3 Million - $21.3 Million	82,500 Added 4125.0%	84,500 $21 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $432,760 - $515,340	2,000 New	2,000 $460,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $728,960 - $966,800	-4,000 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $756,840 - $972,800	-4,000 Reduced 50.0%	4,000 $964,000
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $666,800 - $781,640	4,000 Added 100.0%	8,000 $1.47 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $723,480 - $815,520	4,000 New	4,000 $760,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.